AlaninePlacebo EffectDouble-Blind MethodAlanine TransaminaseAlanine RacemaseInterleukin-1betabeta 2-MicroglobulinAlanine DehydrogenaseGentian VioletReceptors, Adrenergic, betaIntegrin beta3PhenazinesMolecular Sequence DataCross-Over StudiesTreatment OutcomeTransforming Growth Factor betaAmino Acid SequenceMutagenesis, Site-DirectedDose-Response Relationship, DrugTime FactorsRecombinant ProteinsIntegrin alpha5beta1Integrin beta4Aspartate AminotransferasesKineticsBase SequenceBinding SitesIntegrin alpha6beta4Integrin beta Chainsbeta 2-Glycoprotein IAmino AcidsCell LineMutationAmino Acid SubstitutionIntegrin alpha4beta1Receptors, Adrenergic, beta-2Administration, OralIntegrin alpha2beta1LiverCells, CulturedModels, MolecularInterleukin-1IntegrinsDrug Therapy, CombinationAntigens, CD29RNA, MessengerIntegrin alpha6beta1PhosphorylationReceptors, Adrenergic, beta-1Signal TransductionProtein ConformationAdrenergic beta-AgonistsStructure-Activity RelationshipGlycogen Synthase Kinase 3Integrin alpha1beta1Sequence Homology, Amino AcidEscherichia coliTransfectionRandomized Controlled Trials as TopicEstrogen Receptor betaTransforming Growth Factor beta1Gram-Negative BacteriaPropanolaminesDrug Administration ScheduleClinical Trials as TopicCloning, MolecularGlutamineRandom AllocationAdrenergic beta-2 Receptor AgonistsReceptors, Adrenergic, beta-3Cell AdhesionSerineTransaminasesAdrenergic beta-AntagonistsPeptide FragmentsAntibodies, MonoclonalMice, Inbred C57BLGram-Positive BacteriaProtein Structure, SecondaryRecombinant Fusion ProteinsMacromolecular SubstancesBeta RhythmGene Expression RegulationDNA PrimersProspective StudiesSubstrate SpecificityAlbuterolAnalysis of VariancePlant ExtractsDNA Polymerase betaProtein SubunitsCricetinaeGene Expressionbeta CateninGlycineSingle-Blind MethodCattleInsulinSequence AlignmentGlucose